Reference : Diabete de type 2 et medicaments anti-inflammatoires: nouvelles perspectives therapeutiq...
Scientific journals : Article
Human health sciences : Endocrinology, metabolism & nutrition
Human health sciences : Pharmacy, pharmacology & toxicology
http://hdl.handle.net/2268/105085
Diabete de type 2 et medicaments anti-inflammatoires: nouvelles perspectives therapeutiques?
French
[en] Type 2 diabetes and anti-inflammatory agents: new therapeutic prospects?
Esser, Nathalie mailto [Université de Liège - ULg > > GIGA-R : Virologie - Immunologie]
Paquot, Nicolas mailto [Université de Liège - ULg > Services généraux (Faculté de médecine) > Relations académiques et scientifiques (Médecine)]
SCHEEN, André mailto [Centre Hospitalier Universitaire de Liège - CHU > > Diabétologie,nutrition, maladies métaboliques]
2011
Revue Médicale Suisse
7
306
1614-8, 1620
Yes (verified by ORBi)
1660-9379
Switzerland
[en] Anti-Inflammatory Agents/therapeutic use ; Diabetes Mellitus, Type 2/therapy ; Humans ; Metabolic Syndrome X/drug therapy
[en] It is now well accepted that a chronic, low-grade inflammation is observed in abdominal obesity, insulin resistance and type 2 diabetes mellitus, and that pro-inflammatory cytokines and oxidative stress play a role in the pathogenesis of type 2 diabetes. These new findings raise the question of whether antiinflammatory strategies may have a place in the prevention and treatment of type 2 diabetes. This review article describes the results obtained in studies on patients with metabolic syndrome or type 2 diabetes aiming to test the metabolic effect of anti-inflammatory (salicylates, antagonists of interleukine-1, antagonists of tumor necrosis factor-alpha) and anti-oxydants (succinobucol) drugs.
Researchers ; Professionals
http://hdl.handle.net/2268/105085

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
Diabète de type 2 et médicaments anti inflammatoires.pdfPublisher postprint592.79 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.